WYDUR Board Meeting Minutes

January 27, 2005

Cheyenne, Wyoming

 

Members Present: Steve Brown, Richard Johnson, Lenny Kosirog, Mike Carpenter, Dean Winsch, Bill Harrison, Scott Johnston, Antoinette Brown, Kendra Grande, Becky Drnas, Roxanne Homar, Deb Devereaux, George Zaharas, Linda Martin

 

Members Excused: Kay Kohler

 

Guests: Michelle Harker, Teri Green, Greg Gruman, Jamie Cronebaugh (SOP student), Darren Darnell (Pfizer), Larry Bridger (Pfizer), Christi Genke (Forest), Lori Howarth (Berlex), Alan Sloan (Purdue), Danny Ottosen (Mylan Bertek), Laura Hill (Takeda), Mike Ross (Takeda), Bob Schultz (BCBS Wyo), Jeff Jenkins (Merck), Joan Solem (Lilly), Pat Teegarden (Schering-Plough), Richard Leslie (Wyoming Epilepsy Association), Hank Gardner

 

The meeting was called to order at 11:10a.m. The minutes of the November 2004 meeting were approved as presented.

 

Department of Health

Teri Green and Michelle Harker presented information about the APS-disease management contract. The Board discussed contract finances, what are the measured outcomes, etc.

 

Roxanne updated the Board on legislative initiatives.  HB194 dealing with a prescription drug repository passed as a voluntary, drug donation program for unit doses. A MK prescription amendment was defeated unanimously. It would have overridden PA by a prescriber writing Brand Medically Necessary. The Wyoming Medical Society was not in support of this bill. The Pharmacist Adult Immunization Bill would require pharmacists to have special education to administer PneumoVax or flu vaccine. The Board discussed the risks of anaphylaxis and malpractice insurance.

 

The Dept of Health is beginning to figure out the impact of the Medicare drug benefit on the dual eligible population and the budgetary impact on the state.

 

Prior Authorization

Letters were sent to providers informing them of the PDL criteria for calcium channel blockers, skeletal muscle relaxants and long acting opioids. The Board discussed liability regarding PA appeals. The University of Wyoming counsel’s opinion is that as long as the Board is acting within the scope of its responsibility and authority, no individual liability exists. Additionally, the decisions of the Board are advisory to the Dept and are not binding. Protonix was added as a preferred PPI and enalapril was added as a preferred ACEI.

 

The Board approved draft criteria for the non-sedating antihistamines as follows:

 

 

Text Box: Preferred agent: OTC loratadine/loratadine-D An appeal for a non-preferred agent would be considered with the following criteria: □ Chronic idiopathic urticaria □ Patient allergic to or had unacceptable side effects to preferred agent □ 14 day trial and failure of preferred agent within previous 12 months

 

 

 

 

 

 

 

 

 

 

 

 

 

Dermatologists, ENTs, EDs, Pulmonologists and the top 50 FP prescribers will be sent the draft criteria for comment.

 

Dr. Johnston presented his information on essential hypertension which will be published in the next WYDUR Newsletter.

 

There were no comments in the open comment period.

 

Dr. Gardner presented his program showing the highest utilizers of state resources. The largest state expenditure in MK is for medical services.  Dr. Gardner is working to implement a case management program for many of the state programs.

 

Alert Changes

Suppress criteria #115, 501 and 564 (bronchodilators and anxiety)

Suppress #1027

 

There being no further business, the meeting was adjourned at 2:45p.m. The next meeting is March 31 in Laramie.

 

Respectfully Submitted,

 

Debra S. Devereaux MBA, FASHP

DUR Manager